These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Determination of pharmacokinetic properties of clozapine and norclozapine in Korean schizophrenia patients. Lee ST; Ryu S; Nam HJ; Lee SY; Hong KS Int Clin Psychopharmacol; 2009 May; 24(3):139-44. PubMed ID: 19194306 [TBL] [Abstract][Full Text] [Related]
7. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients. Hermida J; Paz E; Tutor JC Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461 [TBL] [Abstract][Full Text] [Related]
8. [Clozapine-resistant schizophrenia related to an increased metabolism and benefit of fluvoxamine: four case reports]. Papetti F; Morel-Pingault V; Buisse V; Maziere L; Banayan M; Thauby S; Besnard T; Darcourt G; Pringuey D Encephale; 2007 Oct; 33(5):811-8. PubMed ID: 18357853 [TBL] [Abstract][Full Text] [Related]
9. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients. Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203 [TBL] [Abstract][Full Text] [Related]
10. Potential Role of Patients' CYP3A-Status in Clozapine Pharmacokinetics. Tóth K; Csukly G; Sirok D; Belic A; Kiss Á; Háfra E; Déri M; Menus Á; Bitter I; Monostory K Int J Neuropsychopharmacol; 2017 Jul; 20(7):529-537. PubMed ID: 28340122 [TBL] [Abstract][Full Text] [Related]
11. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement. van der Weide J; Steijns LS; van Weelden MJ Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594 [TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of clozapine and norclozapine in the prediction of relapse of patients with schizophrenia. Xiang YQ; Zhang ZJ; Weng YZ; Zhai YM; Li WB; Cai ZJ; Tan QR; Wang CY Schizophr Res; 2006 Apr; 83(2-3):201-10. PubMed ID: 16524698 [TBL] [Abstract][Full Text] [Related]
13. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151 [TBL] [Abstract][Full Text] [Related]
14. Impact of CYP1A2, CYP2C19, and CYP2D6 genotype- and phenoconversion-predicted enzyme activity on clozapine exposure and symptom severity. Lesche D; Mostafa S; Everall I; Pantelis C; Bousman CA Pharmacogenomics J; 2020 Apr; 20(2):192-201. PubMed ID: 31616047 [TBL] [Abstract][Full Text] [Related]
15. Clozapine pharmacokinetics in children and adolescents with childhood-onset schizophrenia. Frazier JA; Cohen LG; Jacobsen L; Grothe D; Flood J; Baldessarini RJ; Piscitelli S; Kim GS; Rapoport JL J Clin Psychopharmacol; 2003 Feb; 23(1):87-91. PubMed ID: 12544379 [TBL] [Abstract][Full Text] [Related]
16. Clozapine and oral contraceptives: a possible drug interaction. Gabbay V; O'Dowd MA; Mamamtavrishvili M; Asnis GM J Clin Psychopharmacol; 2002 Dec; 22(6):621-2. PubMed ID: 12454563 [No Abstract] [Full Text] [Related]
17. The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients. Piwowarska J; Radziwoń-Zaleska M; Dmochowska M; Szepietowska E; Matsumoto H; Sygitowicz G; Pilc A; Łukaszkiewicz J Pharmacol Rep; 2016 Dec; 68(6):1120-1125. PubMed ID: 27588387 [TBL] [Abstract][Full Text] [Related]
18. CSF and serum concentrations of clozapine and its demethyl metabolite: a pilot study. Nordin C; Almé B; Bondesson U Psychopharmacology (Berl); 1995 Nov; 122(2):104-7. PubMed ID: 8848524 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring of clozapine and relapse--a retrospective study of routine clinical data. Ulrich S; Baumann B; Wolf R; Lehmann D; Peters B; Bogerts B; Meyer FP Int J Clin Pharmacol Ther; 2003 Jan; 41(1):3-13. PubMed ID: 12564740 [TBL] [Abstract][Full Text] [Related]
20. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. Raaska K; Raitasuo V; Neuvonen PJ Eur J Clin Pharmacol; 2001 Dec; 57(10):705-8. PubMed ID: 11829199 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]